Question · asked by 1 review
Fexofenadine 120 mg/d vs placebo (1‐week intervention): Pruritus
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Fexofenadine 120 mg/d vs placebo (1‐week intervention) Primary outcome 1. Mean change in patient‐assessed symptoms This outcome was measured as the mean change in patient‐assessed pruritus (range 0 to 8) between baseline and the night of day 6 · adults with eczema Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema (2019) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 400 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema 2019 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.